Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308292737> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W4308292737 endingPage "219" @default.
- W4308292737 startingPage "217" @default.
- W4308292737 abstract "Objective: To review selected recent studies on the therapeutic applications of nanoparticles and nanoparticle-conjugated antimicrobials as new therapeutic alternatives for a variety of intracellular infections.
 Data Sources: Recent published papers on nanoparticles and intracellular infections, including bacterial, viral, and parasitic diseases in humans. The PubMed database was used as the main source. Publicly available papers were retrieved.
 Summary of Contents: Therapeutic failure in intracellular infections is a challenging clinical problem. Antibiotics, anti-parasitics, antivirals, and other drugs might not reach effective levels in intracellular compartments; these agents in high doses might become toxic and may show undesirable effects. Researchers have been looking for alternative strategies for antimicrobials to reach intracellular spaces. The development of novel drugs and release mechanisms is currently a research priority in infectious diseases. With this background, new approaches such as those based on nanotechnology, including the fabrication of drug nanocarriers, are of increasing interest to researchers and clinicians. The goal for nanocarriers is to provide controlled release of drugs into cellular compartments with high selectivity, higher efficiency, better therapeutic outcomes, less toxicity, and more rational dosing schemes compared to traditional ones. Biocompatibility of nanocarriers may ensure affinity to the reticuloendothelial and immunological systems, which might facilitate drug delivery into intracellular compartments.
 Conclusion: Nanoparticle systems have great potential in infectious diseases, particularly in difficult-to-treat infections, such as those caused by intracellular pathogens. These systems have been tested with several drugs, enzymes, genes, and peptides, showing long half-lives due to their hydrophilic coatings. The optimization of nanoparticle-based drug delivery systems has improved our understanding of the different mechanisms underlying biological interactions and the engineering of even more complex nanoparticles.
 Keywords: Nanoparticles, intracellular infections, novel therapeutics." @default.
- W4308292737 created "2022-11-10" @default.
- W4308292737 creator A5009754214 @default.
- W4308292737 creator A5058035952 @default.
- W4308292737 creator A5076062673 @default.
- W4308292737 date "2022-10-15" @default.
- W4308292737 modified "2023-09-27" @default.
- W4308292737 title "Nanoparticle applications in intracellular infections" @default.
- W4308292737 doi "https://doi.org/10.22270/jddt.v12i5-s.5738" @default.
- W4308292737 hasPublicationYear "2022" @default.
- W4308292737 type Work @default.
- W4308292737 citedByCount "0" @default.
- W4308292737 crossrefType "journal-article" @default.
- W4308292737 hasAuthorship W4308292737A5009754214 @default.
- W4308292737 hasAuthorship W4308292737A5058035952 @default.
- W4308292737 hasAuthorship W4308292737A5076062673 @default.
- W4308292737 hasBestOaLocation W43082927371 @default.
- W4308292737 hasConcept C15083742 @default.
- W4308292737 hasConcept C155672457 @default.
- W4308292737 hasConcept C171250308 @default.
- W4308292737 hasConcept C18150654 @default.
- W4308292737 hasConcept C192562407 @default.
- W4308292737 hasConcept C2780035454 @default.
- W4308292737 hasConcept C55493867 @default.
- W4308292737 hasConcept C71924100 @default.
- W4308292737 hasConcept C79879829 @default.
- W4308292737 hasConcept C86803240 @default.
- W4308292737 hasConcept C98274493 @default.
- W4308292737 hasConceptScore W4308292737C15083742 @default.
- W4308292737 hasConceptScore W4308292737C155672457 @default.
- W4308292737 hasConceptScore W4308292737C171250308 @default.
- W4308292737 hasConceptScore W4308292737C18150654 @default.
- W4308292737 hasConceptScore W4308292737C192562407 @default.
- W4308292737 hasConceptScore W4308292737C2780035454 @default.
- W4308292737 hasConceptScore W4308292737C55493867 @default.
- W4308292737 hasConceptScore W4308292737C71924100 @default.
- W4308292737 hasConceptScore W4308292737C79879829 @default.
- W4308292737 hasConceptScore W4308292737C86803240 @default.
- W4308292737 hasConceptScore W4308292737C98274493 @default.
- W4308292737 hasIssue "5-S" @default.
- W4308292737 hasLocation W43082927371 @default.
- W4308292737 hasOpenAccess W4308292737 @default.
- W4308292737 hasPrimaryLocation W43082927371 @default.
- W4308292737 hasRelatedWork W1595862141 @default.
- W4308292737 hasRelatedWork W1971079914 @default.
- W4308292737 hasRelatedWork W1992734050 @default.
- W4308292737 hasRelatedWork W2092181605 @default.
- W4308292737 hasRelatedWork W2407162687 @default.
- W4308292737 hasRelatedWork W2790347249 @default.
- W4308292737 hasRelatedWork W2917535482 @default.
- W4308292737 hasRelatedWork W2947366936 @default.
- W4308292737 hasRelatedWork W2999894839 @default.
- W4308292737 hasRelatedWork W4200280043 @default.
- W4308292737 hasVolume "12" @default.
- W4308292737 isParatext "false" @default.
- W4308292737 isRetracted "false" @default.
- W4308292737 workType "article" @default.